Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6395268

Title:Lymphotactin uses
Inventors:Hedrick, Joseph A.; South River, NJ, USA
Hudak, SUSA
n A.; Redwood City, CA, USA
Rennick, Donna M.; Los Altos, CA, USA
Zlotnik, Albert; Palo Alto, CA, USA
Summary:This invention introduces methods of reducing allogeneic reactions from tissue transplants in mammals, and methods of reducing the migration of natural killer cells or T cells, via the administration of an antagonist of mammalian lymphotactin. Described herein are lymphotactin and lymphotactin antagonists for the administration to an animal, and methods by which their administration will either attract certain cell types, or can be blocked to prevent such attraction. Therapeutic applications in the protection of stem cells are included.
Abstract:This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6395268
Application Number:US1999000457501
Date Filed:08/12/1999
Date Published:28/05/2002
Assignee:Schering Corporation, Kenilworth, NJ, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/18/2021